Genetic testing for the risk of developing late effects among survivors of childhood cancer: Consumer understanding, acceptance, and willingness to pay-Reference-Cited by-同舟云学术

Genetic testing for the risk of developing late effects among survivors of childhood cancer: Consumer understanding, acceptance, and willingness to pay

Published:2016-06-03 Issue:18 Volume:122 Page:2876-2885
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Georgiou Gabrielle¹²,Wakefield Claire E.¹²,McGill Brittany C.¹²,Fardell Joanna E.¹²,Signorelli Christina¹²,Hanlon Lucy¹²^ORCID,Tucker Kathy³⁴,Patenaude Andrea F.⁵⁶,Cohn Richard J.¹²

Affiliation:

1. Discipline of Paediatrics, School of Women's and Children's Health, University of New South Wales Medicine; University of New South Wales; Sydney New South Wales Australia

2. Behavioral Sciences Unit proudly supported by the Kids with Cancer Foundation, Kids Cancer Centre; Sydney Children's Hospital; Randwick New South Wales Australia

3. Hereditary Cancer Clinic, Department of Medical Oncology; Prince of Wales Hospital; Randwick New South Wales Australia

4. Prince of Wales Clinical School; University of New South Wales; Sydney New South Wales Australia

5. Department of Psychosocial Oncology and Palliative Care; Dana-Farber Cancer Institute; Boston Massachusetts

6. Department of Psychiatry; Harvard Medical School; Boston Massachusetts

Funder

Kids with Cancer Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Cancer patients acceptance, understanding, and willingness-to-pay for pharmacogenomic testing;Cuffe;Pharmacogenet Genomics.,2014